Cresset Asset Management’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $229K | Sell |
16,716
-271
| -2% | -$3.71K | ﹤0.01% | 1423 |
|
|
2025
Q1 | $188K | Buy |
16,987
+271
| +2% | +$3K | ﹤0.01% | 1521 |
|
|
2024
Q4 | $178K | Hold |
16,716
| – | – | ﹤0.01% | 1555 |
|
|
2024
Q3 | $212K | Hold |
16,716
| – | – | ﹤0.01% | 1926 |
|
|
2024
Q2 | $280K | Sell |
16,716
-133
| -0.8% | -$2.23K | ﹤0.01% | 1709 |
|
|
2024
Q1 | $253K | Buy |
16,849
+133
| +0.8% | +$2K | ﹤0.01% | 1647 |
|
|
2023
Q4 | $251K | Hold |
16,716
| – | – | ﹤0.01% | 1559 |
|
|
2023
Q3 | $234K | Sell |
16,716
-477
| -3% | -$6.68K | ﹤0.01% | 1512 |
|
|
2023
Q2 | $178K | Buy |
+17,193
| New | +$178K | ﹤0.01% | 1622 |
|